Literature DB >> 25643321

Structural basis for amyloidogenic peptide recognition by sorLA.

Yu Kitago1, Masamichi Nagae1, Zenzaburo Nakata1, Maho Yagi-Utsumi2, Shizuka Takagi-Niidome1, Emiko Mihara1, Terukazu Nogi3, Koichi Kato2, Junichi Takagi1.   

Abstract

SorLA is a neuronal sorting receptor considered to be a major risk factor for Alzheimer's disease. We have recently reported that it directs lysosomal targeting of nascent neurotoxic amyloid-β (Aβ) peptides by directly binding Aβ. Here, we determined the crystal structure of the human sorLA domain responsible for Aβ capture, Vps10p, in an unbound state and in complex with two ligands. Vps10p assumes a ten-bladed β-propeller fold with a large tunnel at the center. An internal ligand derived from the sorLA propeptide bound inside the tunnel to extend the β-sheet of one of the propeller blades. The structure of the sorLA Vps10p-Aβ complex revealed that the same site is used. Peptides are recognized by sorLA Vps10p in redundant modes without strict dependence on a particular amino acid sequence, thus suggesting a broad specificity toward peptides with a propensity for β-sheet formation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25643321     DOI: 10.1038/nsmb.2954

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  45 in total

Review 1.  VPS10P-domain receptors - regulators of neuronal viability and function.

Authors:  Thomas E Willnow; Claus M Petersen; Anders Nykjaer
Journal:  Nat Rev Neurosci       Date:  2008-11-12       Impact factor: 34.870

2.  Dynamic equilibrium engagement of a polyvalent ligand with a single-site receptor.

Authors:  Tanja Mittag; Stephen Orlicky; Wing-Yiu Choy; Xiaojing Tang; Hong Lin; Frank Sicheri; Lewis E Kay; Mike Tyers; Julie D Forman-Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-13       Impact factor: 11.205

3.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.

Authors:  Sander Pronk; Szilárd Páll; Roland Schulz; Per Larsson; Pär Bjelkmar; Rossen Apostolov; Michael R Shirts; Jeremy C Smith; Peter M Kasson; David van der Spoel; Berk Hess; Erik Lindahl
Journal:  Bioinformatics       Date:  2013-02-13       Impact factor: 6.937

Review 4.  The LDL receptor: how acid pulls the trigger.

Authors:  Natalia Beglova; Stephen C Blacklow
Journal:  Trends Biochem Sci       Date:  2005-06       Impact factor: 13.807

5.  Activation and functional characterization of the mosaic receptor SorLA/LR11.

Authors:  L Jacobsen; P Madsen; C Jacobsen; M S Nielsen; J Gliemann; C M Petersen
Journal:  J Biol Chem       Date:  2001-04-09       Impact factor: 5.157

6.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease.

Authors:  Clemens R Scherzer; Katrin Offe; Marla Gearing; Howard D Rees; Guofu Fang; Craig J Heilman; Chica Schaller; Hideaki Bujo; Allan I Levey; James J Lah
Journal:  Arch Neurol       Date:  2004-08

7.  NMR characterization of the interaction of GroEL with amyloid β as a model ligand.

Authors:  Maho Yagi-Utsumi; Tomoko Kunihara; Takashi Nakamura; Yoshinori Uekusa; Koki Makabe; Kunihiro Kuwajima; Koichi Kato
Journal:  FEBS Lett       Date:  2013-04-18       Impact factor: 4.124

8.  Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.

Authors:  Sara E Dodson; Olav M Andersen; Vinit Karmali; Jason J Fritz; Dongmei Cheng; Junmin Peng; Allan I Levey; Thomas E Willnow; James J Lah
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  21 in total

Review 1.  The diversity and utility of amyloid fibrils formed by short amyloidogenic peptides.

Authors:  Zahraa S Al-Garawi; Kyle L Morris; Karen E Marshall; Jutta Eichler; Louise C Serpell
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

2.  Phosphatidylinositol (3,4,5)-trisphosphate binds to sortilin and competes with neurotensin: Implications for very low density lipoprotein binding.

Authors:  Robert P Sparks; Jermaine L Jenkins; Gregory E Miner; Yan Wang; Wayne C Guida; Charles E Sparks; Rutilio A Fratti; Janet D Sparks
Journal:  Biochem Biophys Res Commun       Date:  2016-09-22       Impact factor: 3.575

3.  APP Binds to the EGFR Ligands HB-EGF and EGF, Acting Synergistically with EGF to Promote ERK Signaling and Neuritogenesis.

Authors:  Odete A B da Cruz E Silva; Sandra I Vieira; Joana F da Rocha; Luísa Bastos; Sara C Domingues; Ana R Bento; Uwe Konietzko
Journal:  Mol Neurobiol       Date:  2020-10-02       Impact factor: 5.590

Review 4.  Trafficking in Alzheimer's Disease: Modulation of APP Transport and Processing by the Transmembrane Proteins LRP1, SorLA, SorCS1c, Sortilin, and Calsyntenin.

Authors:  Simone Eggert; Carolin Thomas; Stefan Kins; Guido Hermey
Journal:  Mol Neurobiol       Date:  2017-10-27       Impact factor: 5.590

5.  Distinct Functions for Anterograde and Retrograde Sorting of SORLA in Amyloidogenic Processes in the Brain.

Authors:  Sonya B Dumanis; Tilman Burgert; Safak Caglayan; Annette Füchtbauer; Ernst-Martin Füchtbauer; Vanessa Schmidt; Thomas E Willnow
Journal:  J Neurosci       Date:  2015-09-16       Impact factor: 6.167

6.  SorLA in Interleukin-6 Signaling and Turnover.

Authors:  Jakob Vejby Larsen; Claus Munck Petersen
Journal:  Mol Cell Biol       Date:  2017-05-16       Impact factor: 4.272

7.  SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry.

Authors:  Jakob V Larsen; Claus M Petersen
Journal:  J Vis Exp       Date:  2017-01-06       Impact factor: 1.355

8.  A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's disease.

Authors:  Jan Verheijen; Tobi Van den Bossche; Julie van der Zee; Sebastiaan Engelborghs; Raquel Sanchez-Valle; Albert Lladó; Caroline Graff; Håkan Thonberg; Pau Pastor; Sara Ortega-Cubero; Maria A Pastor; Luisa Benussi; Roberta Ghidoni; Giuliano Binetti; Jordi Clarimon; Alberto Lleó; Juan Fortea; Alexandre de Mendonça; Madalena Martins; Oriol Grau-Rivera; Ellen Gelpi; Karolien Bettens; Ligia Mateiu; Lubina Dillen; Patrick Cras; Peter P De Deyn; Christine Van Broeckhoven; Kristel Sleegers
Journal:  Acta Neuropathol       Date:  2016-03-30       Impact factor: 17.088

9.  SORLA attenuates EphA4 signaling and amyloid β-induced neurodegeneration.

Authors:  Timothy Y Huang; Yingjun Zhao; Lu-Lin Jiang; Xiaoguang Li; Yan Liu; Yu Sun; Juan C Piña-Crespo; Bing Zhu; Eliezer Masliah; Thomas E Willnow; Elena B Pasquale; Huaxi Xu
Journal:  J Exp Med       Date:  2017-11-07       Impact factor: 14.307

10.  Dimerization of sortilin regulates its trafficking to extracellular vesicles.

Authors:  Shinsuke Itoh; Ken Mizuno; Masanori Aikawa; Elena Aikawa
Journal:  J Biol Chem       Date:  2018-01-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.